Antistaphylococcal evaluation of indole-naphthalene hybrid analogs

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Antimicrobial Resistance

Background:

• Antibiotic resistance, particularly from Staphylococcus aureus and methicillin-resistant S. aureus (MRSA), poses a significant threat to public health.
• Existing antibiotics often fail against resistant strains, necessitating the development of novel therapeutic agents.
• Natural product antibiotics possess complex structures, hindering efficient chemical synthesis.

Purpose of the Study:

• To develop novel small-molecule antibacterials with accessible synthesis routes.
• To investigate the structure-activity relationship of indolonaphthalene derivatives against Staphylococcus strains.
• To identify potent and non-toxic lead compounds for treating resistant bacterial infections.

Main Methods:

• A one-pot synthesis strategy was employed to create novel indolonaphthalene-based small molecules.
• Various indole substitutions and their positional effects on the molecular scaffold were systematically evaluated.
• Antibacterial activity was assessed against Staphylococcus strains, including MRSA.
• Cytotoxicity was evaluated using human HEK and SH-SY5Y cell lines.

Main Results:

• Novel small-molecule antibacterials based on an indolonaphthalene core were successfully synthesized.
• Antibacterial activity was significantly influenced by the type and position of indole substitutions.
• Compounds with 5-chloro, 5-cyano, and 5-hydroxyl indole substitutions exhibited the strongest antibacterial effects.
• The identified lead compounds demonstrated potent activity, outperforming standard antibiotics against MRSA.
• No significant toxicity was observed in human HEK and SH-SY5Y cells.

Conclusions:

• Easily synthesized indolonaphthalene derivatives represent promising candidates for novel antibacterial therapies.
• Specific indole substitutions enhance antibacterial potency, particularly against MRSA.
• These non-toxic lead compounds offer a potential solution to combat the growing problem of antibiotic resistance.